Abstract:OBJECTIVE:To study the clinicopathologic features, differential diagnosis and prognosis of renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.METHODS:The histopathologic findings and immunophenotype of 11 cases of renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions were studied. Follow-up data (ranged from 10 to 112 months) were also analyzed.RESULTS:There were a total of 7 females and 4 males. The age of patients ranged from 8 to 26 years (mean = 16.3 years). The diameter of the tumors varied from 2.5 to 6.0 cm. Histologically, two morphologic patterns were seen. The first pattern consisted of alveolar, papillary or nested architecture. The tumor cells contained voluminous, clear to eosinophilic cytoplasm, distinct cell borders, vesicular chromatin, and prominent nucleoli. Psammoma bodies were frequently found and could be abundant. In contrast, the second pattern was composed of nested and compact architecture. The tumor cells possessed less abundant cytoplasm and inconspicuous nucleoli. Few psammoma bodies were detected. Immunohistochemical study showed that all cases strongly expressed TFE3, CD10 and P504s. Variable positivity for pan-cytokeratin, epithelial membrane antigen and vimentin was also noted. None of them expressed CK7, Ksp-cadherin and CD117.CONCLUSIONS:Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions is a newly described but rarely encountered subtype of renal cell carcinoma. Pathologic diagnosis can be established when taken age of the patients, histopathologic findings and immunoreactivity for TFE3 protein into consideration.

WITHDRAWN: Comparative study of CT appearances in renal carcinoma associated with Xp11.2 translocation/TFE gene fusion and papillary renal cell carcinoma.

WITHDRAWN: Research and Application of Laparoscopic Precision Pancreatic Cancer Surgery Based on Three-Dimensional Reconstruction

Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases

RETRACTED: The comparative study of tumor angiogenesis and CT enhancement in pancreatic carcinoma

Withdrawn: CIP2A Promotes the Survival of Renal Clear Cell Carcinoma Caki‐2 Cells

WITHDRAWN: Sacroanterior Extrarenal Wilms Tumor: Case Report and Literature Review

WITHDRAWN: WITHDRAWN: Identification of Abnormally Expressed Genes and Their Roles in Invasion and Migration of Hepatocellular Carcinoma

Retracted: Clinical Comparison of Endoscopic Ultrasonography and CT in Preoperative TN Staging of Esophagogastric Junction Cancer

WITHDRAWN: Polymorphisms Rs2073618 and Rs3102735 in TNFRSF11B with the Susceptibility to Gastric Cancer

WITHDRAWN: Two Novel Heterozygous Mutations of CSA Cause Cockayne Syndrome in a Chinese Family.

WITHDRAWN: CRISPR/Cas9 Mediated HPV and PD1 Inhibition Produces a Synergistic Anti-Tumor Effect on Cervical Cancer.

WITHDRAWN: Mir-504 Affects the Radio-Resistance in Nasopharyngeal Carcinoma by Down-Regulating the Expression of Nuclear Respiratory Factor 1

Renal Cell Carcinoma Associated with Xp11.2 Translocations/tfe3 Gene Fusions: a Study of 11 Cases and Review of Literature

WITHDRAWN: Therapeutic Efficacy of Focal Adhesion Kinase Downregulation in REH Cells by RNA Interference

WITHDRAWN: Clinical Features and Outcomes of Infant Acute Lymphoblastic Leukemia from a Single Center in China

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Clinical and Pathological Analysis on Xp11.2 Translocation/tfe3 Gene Fusion-Related Renal Carcinoma

WITHDRAWN: Spleen Tyrosine Kinase (SYK) Protects Renal Tubular Epithelial Cell Against Hypoxia Injury in Children with Acute Kidney Injury.

Retracted: Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance

WITHDRAWN: Treatment of Combining Antiangiogenic Therapy and Cytotoxic Chemotherapy Reduce the Cancer Stem-Like Cell Fraction in Hepatocarcinoma Xenografts

WITHDRAWN: Proteomic Analysis of Plasma-Derived Exosomes Identifies Biomarkers That Distinguish Brain and Liver Metastasis in Lung Cancer Patients.